Clinical trial
Safety and Efficacy of Topical Pazopanib in Treatment of Corneal Neovascularization
NCT01257750 is registered in ClinicalTrials.gov with Reza Dana, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Topical Pazopanib in Treatment of Corneal Neovascularization
- Lead sponsor
- Reza Dana, MD
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- January 31, 2012
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.